Mary L. Smith, a director at $PTCT, sold 5,834 shares of the company on 07-09-2026 for an estimated $525,060. We received data on the trade from a recent SEC filing. This was a sale of approximately 21.1% of their shares of this class of stock. Following this trade, they now own 21,813 shares of this class of $PTCT stock.
$PTCT Insider Trading Activity
$PTCT insiders have traded $PTCT stock on the open market 71 times in the past 6 months. Of those trades, 0 have been purchases and 71 have been sales.
Here’s a breakdown of recent trading of $PTCT stock by insiders over the last 6 months:
- NEIL GREGORY ALMSTEAD (CHIEF TECHNICAL OPS OFFICER) has made 0 purchases and 26 sales selling 166,513 shares for an estimated $13,244,388.
- MARK ELLIOTT BOULDING (EXEC. VP AND CLO) has made 0 purchases and 23 sales selling 29,531 shares for an estimated $2,233,611.
- ERIC PAUWELS (CHIEF BUSINESS OFFICER) has made 0 purchases and 4 sales selling 25,320 shares for an estimated $1,885,761.
- MATTHEW B. KLEIN (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 7 sales selling 25,455 shares for an estimated $1,801,080.
- CHRISTINE MARIE UTTER (SVP, CHIEF ACCOUNTING OFFICER) has made 0 purchases and 2 sales selling 22,180 shares for an estimated $1,660,458.
- STEPHANIE OKEY has made 0 purchases and 3 sales selling 21,500 shares for an estimated $1,463,075.
- MARY L. SMITH has made 0 purchases and 2 sales selling 15,834 shares for an estimated $1,425,060.
- LEE SCOTT GOLDEN (EVP & CHIEF MEDICAL OFFICER) has made 0 purchases and 3 sales selling 13,313 shares for an estimated $862,453.
- PIERRE GRAVIER (CHIEF FINANCIAL OFFICER) sold 2,992 shares for an estimated $207,525
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$PTCT Hedge Fund Activity
We have seen 182 institutional investors add shares of $PTCT stock to their portfolio, and 136 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 1,128,551 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $76,888,179
- TORONTO DOMINION BANK removed 1,112,252 shares (-26.9%) from their portfolio in Q1 2026, for an estimated $75,777,728
- CITADEL ADVISORS LLC removed 769,256 shares (-66.6%) from their portfolio in Q1 2026, for an estimated $52,409,411
- ARMISTICE CAPITAL, LLC removed 727,420 shares (-26.0%) from their portfolio in Q1 2026, for an estimated $49,559,124
- HOOD RIVER CAPITAL MANAGEMENT LLC added 661,484 shares (+65.9%) to their portfolio in Q1 2026, for an estimated $45,066,904
- QUBE RESEARCH & TECHNOLOGIES LTD added 513,823 shares (+inf%) to their portfolio in Q1 2026, for an estimated $35,006,760
- LOOMIS SAYLES & CO L P added 493,603 shares (+inf%) to their portfolio in Q1 2026, for an estimated $33,629,172
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$PTCT Price Targets
Multiple analysts have issued price targets for $PTCT recently. We have seen 8 analysts offer price targets for $PTCT in the last 6 months, with a median target of $92.5.
Here are some recent targets:
- Brian Abrahams from RBC Capital set a target price of $85.0 on 07/07/2026
- Geoff Meacham from Citigroup set a target price of $108.0 on 06/09/2026
- Faisal Khurshid from Jefferies set a target price of $85.0 on 05/27/2026
- Benjamin Burnett from Wells Fargo set a target price of $95.0 on 05/08/2026
- Joseph Thome from TD Cowen set a target price of $90.0 on 05/08/2026
- Jeffrey Hung from Morgan Stanley set a target price of $92.0 on 02/23/2026
- Tazeen Ahmad from B of A Securities set a target price of $93.0 on 02/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
